Factors affecting providers' delivery of intermittent preventive treatment for malaria in pregnancy: A five-country analysis of national service provision assessment surveys

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Maheu Giroux, Mathieu ^a   Castro, Marcia C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT;

ARTICLE; CONSULTATION; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; KENYA; MALARIA; MATERNAL CARE; NAMIBIA; PRACTICE GUIDELINE; PREGNANCY; PREVENTIVE MEDICINE; RISK FACTOR; RWANDA; TANZANIA; UGANDA; AFRICA SOUTH OF THE SAHARA; CHEMOPROPHYLAXIS; COST BENEFIT ANALYSIS; HEALTH CARE PERSONNEL; PREGNANCY COMPLICATIONS, INFECTIOUS; PROCEDURES;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; CHEMOPREVENTION; COST-BENEFIT ANALYSIS; FEMALE; HEALTH PERSONNEL; HUMANS; MALARIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84988874596     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-440     Document Type: Article

References (63)

1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007, 7:93-104.
2. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO: Quantifying the number of pregnancies at risk of malaria in 2007: A demographic study. PLoS Med 2010, 7:e1000221.
3. WHO: WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). Geneva, Switzerland: World Health Organization (WHO) Global Malaria Programme, WHO Department of Reproductive Health and Research, and WHO Department of Maternal, Newborn, Child and Adolescent Health; 2013:12.
4. Garner P, Gölmezoglu AM: Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev 2006, 18:CD000169.
5. Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW: Malaria prevention in pregnancy, birthweight, and neonatal mortality: A meta-Analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis 2012, 12:942-949.
6. Menéndez C, Bardají A, Sigauque B, Sanz S, Aponte JJ, Mabunda S, Alonso PL: Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One 2010, 5:e9438.
7. Eisele TP, Larsen D, Steketee RW: Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas. Int J Epidemiol 2010, 39(Suppl 1):i88-i101.
8. ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: A systematic review. JAMA 2007, 297:2603-2616.
9. Sicuri E, Bardají A, Nhampossa T, Maixenchs M, Nhacolo A, Nhalungo D, Alonso PL, Menéndez C: Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique. PLoS One 2010, 5:e13407.
10. van Eijk AM, Hill J, Alegana VA, Kirui V, Gething PW, ter Kuile FO, Snow RW: Coverage of malaria protection in pregnant women in sub-Saharan Africa: A synthesis and analysis of national survey data. Lancet Infect Dis 2011, 11:190-207.
11. van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, Ter Kuile FO: Coverage of intermittent preventive treatment and insecticidetreated nets for the control of malaria during pregnancy in sub-Saharan Africa: A synthesis and meta-Analysis of national survey data, 2009-11. Lancet Infect Dis 2013, 13:1029-1042.
12. Hill J, Hoyt J, van Eijk AM, D'Mello-Guyett L, Ter Kuile FO, Steketee R, Smith H, Webster J: Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: A systematic review and meta-Analysis. PLoS Med 2013, 10:e1001488.
13. RBM: Refined/Updated Global Malaria Action Plan Objectives, Targets, Milestones and Priorities Beyond 2011. Geneva, Switzerland: Roll Back Malaria Partnership; 2011:6.
14. PMI: The President's Malaria Initiative-Seventh Annual Report to Congress. Washington, DC: United States Agency for International Development, Centers for Disease Control and Prevention, Department of Health & Human Services; 2013:53.
15. Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R: From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis 2007, 7:145-155.
16. WHO: Updated WHO Policy Recommendation-Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethaine (IPTp-SP). Geneva, Switzerland: World Health Organization, Global Malaria Programme; 2012:2.
17. Okeibunor JC, Orji BC, Brieger W, Ishola G, Otolorin E, Rawlins B, Ndekhedehe EU, Onyeneho N, Fink G: Preventing malaria in pregnancy through community-directed interventions: evidence from Akwa Ibom State. Nigeria Malar J 2011, 10:227.
18. Ndyomugyenyi R, Tukesiga E, Katamanywa J: Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of communitydirected distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities. Trans R Soc Trop Med Hyg 2009, 103:1221-1228.
19. Msyamboza KP, Savage EJ, Kazembe PN, Gies S, Kalanda G, D'Alessandro U, Brabin BJ: Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health 2009, 14:183-189.
20. Mbonye AK, Bygbjerg IC, Magnussen P: A community-based delivery system of intermittent preventive treatment of malaria in pregnancy and its effect on use of essential maternity care at health units in Uganda. Trans R Soc Trop Med Hyg 2007, 101:1088-1095.
21. Mbonye AK, Yanow S, Birungi J, Magnussen P: A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda. BMC Pregnancy Childbirth 2013, 13:178.
22. Gies S, Coulibaly SO, Ky C, Ouattara FT, Brabin BJ, D'Alessandro U: Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. Am J Trop Med Hyg 2009, 80:460-469.
23. Ouma PO, Van Eijk AM, Hamel MJ, Sikuku E, Odhiambo F, Munguti K, Ayisi JG, Kager PA, Slutsker L: The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya. Trop Med Int Health 2007, 12:953-961.
24. NCAPD, MOMS, MOPHS, KNBS, ICF Macro: Kenya Service Provision Assessment Survey 2010. Nairobi, Kenya: National Coordinating Agency for Population and Development, Ministry of Medical Services, Ministry of Public Health and Sanitation, Kenya National Bureau of Statistic, and ICF Macro; 2011:660.
25. MoHSS, ICF Macro: Namibia Health Facility Census 2009. Windhoek, Namibia: Ministry of Health and Social Services and ICF Macro; 2010:600.
26. NIS, MoH, Macro International Inc: Rwanda Service Provision Assessment Survey 2007. Claverton, MD: National Institute of Statistics, Ministry of Health, and Macro International Inc; 2008:685.
27. NBS, Inc. MI: Tanzania Service Provision Assessment Survey 2006. Dar es Salaam, Tanzania: National Bureau of Statistics and Macro International Inc; 2007:691.
28. MoH, Macro International Inc: Uganda Service Provision Asssessment Survey 2007. Kampala, Uganda: Ministry of Health and Macro International Inc; 2008:710.
29. NCAPD, MoH, CBS, ORC Macro: Kenya Service Provision Assessment Survey 2004. Nairobi, Kenya: National Coordinating Agency for Population and Development, Ministry of Health, Central Bureau of Statistics, and ORC Macro; 2005:490.
30. Zou G: A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004, 159:702-706.
31. Zou GY, Donner A: Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res 2013, 22:661-670.
32. Yelland LN, Salter AB, Ryan P: Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol 2011, 174:984-992.
33. Betensky RA, Talcott JA, Weeks JC: Binary data with two, non-nested sources of clustering: An analysis of physician recommendations for early prostate cancer treatment. Biostatistics 2000, 1:219-230.
34. Solon G, Haider S, Wooldridge J: What are we weighting for? In NBER Working Paper Series. Cambridge, MA: National Bureau of Economic Research; 2013:29.
35. Miettinen OS: Theoretical Epidemiology : Principles of Occurrence Research in Medicine. New York: Wiley; 1985.
36. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
37. Højsgaard S, Halekoh U, Yan J: The R package geepack for generalized estimating equations. J Stat Softw 2006, 15:1-11.
38. Danaei G, Rimm EB, Oza S, Kulkarni SC, Murray CJ, Ezzati M: The promise of prevention: The effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Med 2010, 7:e1000248.
39. Lincetto O, Mothebesoanne-Anoh S, Gomez P, Munjanja S: Antenatal Care. In Opportunities for Africa's Newborns-Practical Data, Policy and Programmatic Support for Newborn Care in Africa. Edited by Lord D, Wake R, Elder L, Grear K, Antayhua A. Cape Town, South Africa: The Partnership for Maternal, Newborn & Child Health; 2006:51-62.
40. KNBS, ICF Macro: Kenya Demographic and Health Survey 2008-09. Calverton, MD: Kenya National Bureau of Statistics and ICF Macro; 2010:430.
41. MoHSS, Inc. MI: Namibia Demographic and Health Survey 2006-07. Windhoek, Namibia and Calverton, MD: Ministry of Health and Social Services and Macro International Inc; 2008:428.
42. MoH, NISR, ICF Macro: Rwanda Interim Demographic and Health Survey 2007-08. Calverton, MD: Ministry of Health, National Institute of Statistics of Rwanda, and ICF Macro; 2009:190.
43. NBS, ICF Macro: Tanzania Demographic and Health Survey 2010. Dar es Salaam, Tanzania: National Bureau of Statistics (NBS) [Tanzania] and ICF Macro; 2011:451.
44. UBOS, ICF International Inc: Uganda Demographic and Health Survey 2011. Kampala, Uganda: Uganda Bureau of Statistics and ICF International Inc; 2012:315.
45. Mubyazi GM, Bloch P, Byskov J, Magnussen P, Bygbjerg IC, Hansen KS: Supply-related drivers of staff motivation for providing intermittent preventive treatment of malaria during pregnancy in Tanzania: evidence from two rural districts. Malar J 2012, 11:48.
46. Mubyazi GM, Bloch P: Psychosocial, behavioural and health system barriers to delivery and uptake of intermittent preventive treatment of malaria in pregnancy in Tanzania-viewpoints of service providers in Mkuranga and Mufindi districts. BMC Health Serv Res 2014, 14:15.
47. Brentlinger PE, Dgedge M, Correia MA, Rojas AJ, Saúte F, Gimbel-Sherr KH, Stubbs BA, Mercer MA, Gloyd S: Intermittent preventive treatment of malaria during pregnancy in central Mozambique. Bull World Health Organ 2007, 85:873-879.
48. Thiam S, Kimotho V, Gatonga P: Why are IPTp coverage targets so elusive in sub-Saharan Africa? a systematic review of health system barriers. Malar J 2013, 12:353.
49. Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy: A qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania. Malar J 2005, 4:31.
50. Smith LA, Jones C, Adjei RO, Antwi GD, Afrah NA, Greenwood B, Chandramohan D, Tagbor H, Webster J: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J 2010, 9:18.
51. Hill J, Dellicour S, Bruce J, Ouma P, Smedley J, Otieno P, Ombock M, Kariuki S, Desai M, Hamel MJ, ter Kuile FO, Webster J: Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya. PLoS One 2013, 8:e64913.
52. Pell C, Meñaca A, Afrah NA, Manda-Taylor L, Chatio S, Were F, Hodgson A, Hamel MJ, Kalilani L, Tagbor H, Pool R: Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi. Malar J 2013, 12:427.
53. Onoka CA, Onwujekwe OE, Hanson K, Uzochukwu BS: Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors. Malar J 2012, 11:317.
54. Mubyazi GM, Magnussen P, Byskov J, Bloch P: Feasibility and coverage of implementing intermittent preventive treatment of malaria in pregnant women contacting private or public clinics in Tanzania: experiencebased viewpoints of health managers in Mkuranga and Mufindi districts. BMC Health Serv Res 2013, 13:372.
55. Gross K, Alba S, Schellenberg J, Kessy F, Mayumana I, Obrist B: The combined effect of determinants on coverage of intermittent preventive treatment of malaria during pregnancy in the Kilombero Valley, Tanzania. Malar J 2011, 10:140.
56. MoHSS: National Malaria Policy. Windhoek, Namibia: Ministry of Health and Social Services; 2005:40.
57. MoHSW: National Guidelines for Diagnosis and Treatment of Malaria. In Malaria Control Series 11. Dar es Salaam, Tanzania: National Malaria Control Programme, Ministry of Health and Social Welfare; 2006:105.
58. Kenya MoH: National Guidelines for Diagnosis, Treatment and Prevention of Malaria for Health Workers in Kenya. Nairobi, Kenya: Division of Malaria Control, Ministry of Health; 2006:43.
59. WHO: WHO Expert Consultation on Cotrimoxazole Prophylaxis in HIV Infection. In WHO Technical Report Series WHO/HIV/200601. Geneva, Switzerland: World Health Organization; 2006:35.
60. Landsberger HA: Hawthorne Revisited. : Management and the Worker: Its Critics, and Developments in Human Relations in Industry. Ithaca, N.Y.: Cornell University; 1958.
61. Namusoke F, Ntale M, Wahlgren M, Kironde F, Mirembe F: Validity of selfreported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): A cross-sectional study. Malar J 2012, 11:310.
62. Bank W: World Bank Policy Note: Enhancing Public Supply Chain Management in Zambia. Washington, DC: World Bank; 2012.
63. Mikkelsen-Lopez I, Shango W, Barrington J, Ziegler R, Smith T, de Savigny D: The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: The case of Tanzania. Malar J 2014, 13:181.